Walgreens Boots Alliance (NASDAQ:WBA) Issues FY 2025 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) issued an update on its FY 2025 earnings guidance on Friday morning. The company provided EPS guidance of 1.400-1.800 for the period, compared to the consensus EPS estimate of 1.520. The company issued revenue guidance of -. Walgreens Boots Alliance also updated its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Stock Up 27.5 %

Shares of NASDAQ:WBA opened at $11.76 on Friday. Walgreens Boots Alliance has a 52-week low of $8.08 and a 52-week high of $24.93. The firm has a fifty day moving average of $9.26 and a 200 day moving average of $9.89. The firm has a market capitalization of $10.15 billion, a PE ratio of -1.17, a price-to-earnings-growth ratio of 1.36 and a beta of 0.64. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same period in the previous year, the business earned $0.66 earnings per share. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. As a group, research analysts anticipate that Walgreens Boots Alliance will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were given a dividend of $0.25 per share. The ex-dividend date was Monday, November 18th. This represents a $1.00 annualized dividend and a yield of 8.50%. Walgreens Boots Alliance’s payout ratio is -9.99%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Jefferies Financial Group dropped their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. Barclays increased their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 16th. Royal Bank of Canada dropped their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a report on Wednesday, December 4th. Evercore ISI increased their target price on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday, October 16th. Finally, Morgan Stanley decreased their price target on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research note on Friday, October 11th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $12.58.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.